| methylation | GO:0032259 | 134 | 0.071 | |
| negative regulation of t helper 2 cell differentiation | GO:0045629 | 4 | 0.055 | |
| macromolecule methylation | GO:0043414 | 120 | 0.047 | |
| t cell differentiation | GO:0030217 | 174 | 0.042 | |
| rna processing | GO:0006396 | 105 | 0.042 | |
| regulation of cell activation | GO:0050865 | 289 | 0.037 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.036 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.035 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.034 | |
| immune effector process | GO:0002252 | 321 | 0.032 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.031 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.031 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.031 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.030 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.029 | |
| dna alkylation | GO:0006305 | 43 | 0.028 | |
| t cell activation | GO:0042110 | 289 | 0.028 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.027 | |
| dna metabolic process | GO:0006259 | 303 | 0.027 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.027 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.026 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.025 | |
| amine metabolic process | GO:0009308 | 45 | 0.025 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.025 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.024 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.024 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.024 | |
| dna modification | GO:0006304 | 50 | 0.022 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.022 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.022 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.020 | |
| stem cell differentiation | GO:0048863 | 268 | 0.020 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.020 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.020 | |
| microtubule based process | GO:0007017 | 236 | 0.019 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.019 | |
| dna methylation | GO:0006306 | 43 | 0.019 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.019 | |
| b cell activation | GO:0042113 | 161 | 0.019 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.019 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.019 | |
| regulation of t cell differentiation | GO:0045580 | 83 | 0.019 | |
| muscle tissue development | GO:0060537 | 308 | 0.019 | |
| mitotic cell cycle process | GO:1903047 | 159 | 0.018 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.018 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.018 | |
| neuron death | GO:0070997 | 154 | 0.018 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.018 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.018 | |
| cellular response to lipid | GO:0071396 | 145 | 0.018 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.017 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.017 | |
| mrna processing | GO:0006397 | 63 | 0.017 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.017 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.016 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.016 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.016 | |
| nuclear division | GO:0000280 | 158 | 0.016 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.015 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.015 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.015 | |
| mapk cascade | GO:0000165 | 281 | 0.015 | |
| regionalization | GO:0003002 | 337 | 0.015 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.015 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.015 | |
| compound eye development | GO:0048749 | 1 | 0.014 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.014 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.014 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.014 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.014 | |
| organelle fission | GO:0048285 | 170 | 0.014 | |
| regulation of neuron death | GO:1901214 | 134 | 0.014 | |
| regulation of cd4 positive alpha beta t cell activation | GO:2000514 | 24 | 0.013 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.013 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.013 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.013 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.013 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.013 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.013 | |
| organelle assembly | GO:0070925 | 177 | 0.013 | |
| mrna metabolic process | GO:0016071 | 84 | 0.013 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.013 | |
| nuclear transport | GO:0051169 | 139 | 0.013 | |
| cytokine production | GO:0001816 | 319 | 0.012 | |
| oxidation reduction process | GO:0055114 | 342 | 0.012 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.012 | |
| fat cell differentiation | GO:0045444 | 160 | 0.012 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.012 | |
| rna 3 end processing | GO:0031123 | 20 | 0.012 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.012 | |
| inflammatory response | GO:0006954 | 244 | 0.012 | |
| tissue homeostasis | GO:0001894 | 115 | 0.012 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.012 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.012 | |
| innate immune response | GO:0045087 | 157 | 0.012 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.012 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.012 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.012 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.012 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.012 | |
| covalent chromatin modification | GO:0016569 | 163 | 0.011 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.011 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.011 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.011 | |
| positive regulation of glial cell proliferation | GO:0060252 | 4 | 0.011 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.011 | |
| cd4 positive alpha beta t cell differentiation | GO:0043367 | 41 | 0.011 | |
| stem cell development | GO:0048864 | 219 | 0.011 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.011 | |
| adaptive immune response | GO:0002250 | 155 | 0.011 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.011 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.011 | |
| camera type eye development | GO:0043010 | 266 | 0.011 | |
| regulation of actin nucleation | GO:0051125 | 4 | 0.011 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.011 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.011 | |
| muscle cell fate specification | GO:0042694 | 1 | 0.011 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.010 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.010 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.010 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.010 | |
| cation transport | GO:0006812 | 399 | 0.010 | |
| chemotaxis | GO:0006935 | 247 | 0.010 | |
| cellular homeostasis | GO:0019725 | 240 | 0.010 | |
| dna recombination | GO:0006310 | 92 | 0.010 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.010 | |
| placenta development | GO:0001890 | 140 | 0.010 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.010 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.010 | |
| chromatin organization | GO:0006325 | 206 | 0.010 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.010 | |
| negative regulation of leukocyte differentiation | GO:1902106 | 51 | 0.010 | |
| respiratory system development | GO:0060541 | 190 | 0.010 | |
| action potential | GO:0001508 | 78 | 0.010 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.010 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.010 | |
